Kenvue Inc. (KVUE), the consumer health giant behind brands like Tylenol, Listerine, and Neutrogena, reported a slight decline in third-quarter sales but saw an improvement in profitability. The company’s adjusted gross profit margin expanded due to efficiency gains and pricing strategies, while volume decline was mainly driven by Skin Health and Beauty and Self Care segments.
Starboard Value, a prominent activist investor, has reportedly acquired a significant stake in Kenvue Inc., the company behind popular consumer brands like Tylenol and Listerine. The move signals potential changes for Kenvue, which has faced stock underperformance since its spin-off from Johnson & Johnson last year. Starboard’s CEO, Jeff Smith, is expected to outline his plans for Kenvue at an upcoming activist investing conference.
A recent study has raised concerns about the potential health risks associated with regular use of Listerine mouthwash. Researchers found that daily use of Listerine could lead to an increase in bacteria linked to cancer and infections. The study suggests that alcohol-based mouthwashes may disrupt the natural balance of bacteria in the mouth, potentially contributing to health issues. Experts recommend using alcohol-free alternatives and limiting the use of alcohol-based mouthwashes.
